Today, WaferGen Biosystems, Inc. and NuGEN Technologies, Inc. jointly announced that they will co-develop and co-market simple, seamlessly integrated workflows for gene expression profiling. The companies will target enrichment so that researchers can achieve high-throughput, high-density real-time PCR with small, degraded, and hard-to-replace clinical specimens.
The collaborative relationship will allow the companies to conduct joint product development projects. With speed and simplicity as the driving force, the efforts will focus on solutions for sample preparation, preamplification, and nucleic acid detection for gene expression. The two companies will conduct joint product development projects to construct validated workflows with NuGEN’s proprietary sample preparation and isothermal linear amplification (SPIA®) products and the WaferGen SmartChip Real-Time PCR System.
Alnoor Shivji, Chairman and CEO of WaferGen, remarked, “By combining the expertise of both companies, we can offer a simple and straightforward workflow solution for single cell analysis, archival tissues and next generation sequencing addressing the needs of customers with precious nucleic acid samples who wish to perform high-throughput, high-density real-time PCR. This will expand the market potential of our SmartChip System by offering ready-to-go applications for biomarker discovery, validation and screening.”
Elizabeth Hutt, NuGEN Technologies CEO, added, “NuGEN’s unique sample preparation solution integrated with WaferGen’s SmartChip System is clearly synergistic. NuGEN’s expertise in solving the challenges associated with clinical samples, such as formalin-fixed, paraffin-embedded tissues or fine needle aspirates, will be leveraged in a simple workflow from sample to analysis expediting disease research and clinical applications.”